FDA Approved: BASAGLAR KWIKPEN — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA supplemental application approval for BASAGLAR KWIKPEN (insulin glargine) filed by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• BASAGLAR KWIKPEN (Insulin glargine)

Snippet

SUPPL AP for BASAGLAR KWIKPEN (INSULIN GLARGINE)